PHAT NASDAQ
Phathom Pharmaceuticals, Inc.
1W: -5.2%
1M: -25.3%
3M: -39.2%
YTD: -56.0%
1Y: -43.7%
3Y: -32.9%
5Y: -78.3%
$6.92
-0.16 (-2.26%)
Weekly Expected Move ±9.0%
$6
$6
$7
$8
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$240M
Revenue
+110.2% YoY
$-99M
Net Income
+70.0% YoY
$-37M
Free Cash Flow
+86.6% YoY
79.7%
Gross Margin
-5.3%
Op. Margin
-23.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE26.4%
ROA-34.3%
ROIC8.9%
Valuation
P/E-5.4
P/B-1.7
EV/EBITDA-25.4
Leverage
Debt/Equity-0.49
Current Ratio1.92
Interest Cov.-0.6x
Quality Scores
Piotroski F4/9
Altman Z-4.85
Beneish M-2.45